Tokai Pharmaceuticals Taps Jodie Morrison for CEO

Tokai Pharmaceuticals taps Jodie Morrison for CEO

Filed under: drug rehab treatment options

“This is a very exciting time for Tokai as the company continues to advance its lead prostate cancer drug galeterone in the ongoing ARMOR2 Phase 2 study. We believe galeterone has the potential to be an important new treatment option for patients with …
Read more on Boston Globe

 

Federal Panel Creates Massachusetts MDL for GranuFlo, NaturaLyte Lawsuits

Filed under: drug rehab treatment options

The Germany-based company manufactures and markets GranuFlo and NaturaLyte, two drugs commonly used in dialysis treatment. Plaintiffs allege … After weighing all factors, the panel decided an MDL proceeding in Massachusetts is the best option.
Read more on DrugWatch.com

 

Tokai promotes Jodie Morrison to CEO

Filed under: drug rehab treatment options

Tokai is a privately-held biotech focused on treatments for cancer, which in December launched a Phase 2 clinical trial involving up to 196 patients for its lead drug candidate, galeterone (TOK- 001), targeting castration-resistant prostate cancer. “We …
Read more on Boston Business Journal (blog)

 

Struggling with addiction: "I turned into someone I'm not"

Filed under: drug rehab treatment options

Day one looked at a new rehabilitation option in the region. Day two focused on judges and prosecutors dealing with first-time … After Damron's second child was born, she was introduced to the drug Oxycontin. “My habit became expensive, which is what …
Read more on Bucyrus Telegraph Forum